Advertisement
Screener

EDITAS MEDICINE, INC. (EDIT) Increase (Decrease) in Prepaid Expense and Other Assets

EDITAS MEDICINE, INC. Increase (Decrease) in Prepaid Expense and Other Assets

EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05

  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.87M, a 283.40% increase year-over-year.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$248.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$887.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$593.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.06M.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$4.40M, a 2331.47% decline from fiscal 2023.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $197.00K, a 43.80% increase from fiscal 2022.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $137.00K.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.62M
10-Q · filed 2026-08-05
$736.00K
derived: sum of 3 quarters · filed 2026-08-05
$143.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$248.00K
10-Q · filed 2026-05-05
-$1.14M
derived: sum of 2 quarters · filed 2026-05-05
-$1.73M
derived: sum of 3 quarters · filed 2026-05-05
-$1.24M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$887.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$1.48M
derived: sum of 2 quarters · filed 2026-03-09
-$992.00K
derived: sum of 3 quarters · filed 2026-08-05
-$1.06M
10-K · filed 2026-03-09
2025-09-30-$593.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$105.00K
derived: sum of 2 quarters · filed 2026-08-05
-$175.00K
10-Q · filed 2025-11-10
-$2.96M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$488.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$418.00K
10-Q · filed 2026-08-05
-$2.37M
derived: sum of 3 quarters · filed 2026-08-05
-$3.44M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$70.00K
10-Q · filed 2026-05-05
-$2.86M
derived: sum of 2 quarters · filed 2026-05-05
-$3.93M
derived: sum of 3 quarters · filed 2026-05-05
-$6.07M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$3.86M
derived: sum of 2 quarters · filed 2026-03-09
-$6.00M
derived: sum of 3 quarters · filed 2026-03-09
-$4.40M
10-K · filed 2026-03-09
2024-09-30-$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$3.21M
derived: sum of 2 quarters · filed 2025-11-10
-$1.61M
10-Q · filed 2025-11-10
-$639.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$535.00K
10-Q · filed 2025-08-12
$433.00K
derived: sum of 3 quarters · filed 2025-08-12
$273.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$1.61M
10-Q · filed 2025-05-12
$2.58M
derived: sum of 2 quarters · filed 2025-05-12
$2.42M
derived: sum of 3 quarters · filed 2025-05-12
$3.36M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$968.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$808.00K
derived: sum of 2 quarters · filed 2025-03-05
$1.75M
derived: sum of 3 quarters · filed 2025-03-05
$197.00K
10-K · filed 2025-03-05
2023-09-30-$160.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$787.00K
derived: sum of 2 quarters · filed 2024-11-04
-$771.00K
10-Q · filed 2024-11-04
-$327.00K
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30$947.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$611.00K
10-Q · filed 2024-08-07
-$167.00K
derived: sum of 3 quarters · filed 2025-03-05
-$1.38M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31-$1.56M
10-Q · filed 2024-05-08
-$1.11M
derived: sum of 2 quarters · filed 2025-03-05
-$2.33M
derived: sum of 3 quarters · filed 2025-03-05
-$1.52M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31$444.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
-$771.00K
derived: sum of 2 quarters · filed 2025-03-05
$38.00K
derived: sum of 3 quarters · filed 2025-03-05
$137.00K
10-K · filed 2025-03-05
2022-09-30-$1.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
-$406.00K
derived: sum of 2 quarters · filed 2023-11-03
-$307.00K
10-Q · filed 2023-11-03
-$2.62M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$809.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$908.00K
10-Q · filed 2023-08-02
-$1.41M
derived: sum of 3 quarters · filed 2024-02-28
$2.70M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$99.00K
10-Q · filed 2023-05-05
-$2.22M
derived: sum of 2 quarters · filed 2024-02-28
$1.89M
derived: sum of 3 quarters · filed 2024-02-28
$986.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$2.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$1.79M
derived: sum of 2 quarters · filed 2024-02-28
$887.00K
derived: sum of 3 quarters · filed 2024-02-28
-$3.73M
10-K · filed 2024-02-28
2021-09-30$4.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$3.20M
derived: sum of 2 quarters · filed 2022-11-02
-$1.41M
10-Q · filed 2022-11-02
-$952.00K
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$903.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$5.52M
10-Q · filed 2022-08-03
-$5.06M
derived: sum of 3 quarters · filed 2023-02-22
-$4.13M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31-$4.62M
10-Q · filed 2022-05-04
-$4.16M
derived: sum of 2 quarters · filed 2023-02-22
-$3.23M
derived: sum of 3 quarters · filed 2023-02-22
-$1.97M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$462.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$1.39M
derived: sum of 2 quarters · filed 2023-02-22
$2.65M
derived: sum of 3 quarters · filed 2023-02-22
$4.64M
10-K · filed 2023-02-22
2020-09-30$927.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$2.19M
derived: sum of 2 quarters · filed 2021-11-09
$4.18M
10-Q · filed 2021-11-09
$4.94M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.25M
10-Q · filed 2021-08-05
$4.01M
derived: sum of 3 quarters · filed 2022-02-24
$4.05M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$2.00M
10-Q · filed 2021-05-06
$2.75M
derived: sum of 2 quarters · filed 2022-02-24
$2.79M
derived: sum of 3 quarters · filed 2022-02-24
$3.28M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$758.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$796.00K
derived: sum of 2 quarters · filed 2022-02-24
$1.28M
derived: sum of 3 quarters · filed 2022-02-24
$495.00K
10-K · filed 2022-02-24
2019-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$526.00K
derived: sum of 2 quarters · filed 2020-11-06
-$263.00K
10-Q · filed 2020-11-06
$798.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$488.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$301.00K
10-Q · filed 2020-08-07
$760.00K
derived: sum of 3 quarters · filed 2021-02-26
$1.70M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$789.00K
10-Q · filed 2020-05-08
$272.00K
derived: sum of 2 quarters · filed 2021-02-26
$1.21M
derived: sum of 3 quarters · filed 2021-02-26
$1.86M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$2.00M
derived: sum of 2 quarters · filed 2021-02-26
$2.65M
derived: sum of 3 quarters · filed 2021-02-26
$3.41M
10-K · filed 2021-02-26
2018-09-30$935.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.59M
derived: sum of 2 quarters · filed 2019-11-12
$2.35M
10-Q · filed 2019-11-12
$2.69M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$653.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$1.41M
10-Q · filed 2019-08-07
$1.75M
derived: sum of 3 quarters · filed 2020-02-26
$1.52M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$761.00K
10-Q · filed 2019-05-08
$1.10M
derived: sum of 2 quarters · filed 2020-02-26
$871.00K
derived: sum of 3 quarters · filed 2020-02-26
$1.84M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$338.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$110.00K
derived: sum of 2 quarters · filed 2020-02-26
$1.08M
derived: sum of 3 quarters · filed 2020-02-26
$596.00K
10-K · filed 2020-02-26
2017-09-30-$228.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$744.00K
derived: sum of 2 quarters · filed 2018-11-08
$258.00K
10-Q · filed 2018-11-08
-$103.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$972.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$486.00K
10-Q · filed 2018-08-07
$125.00K
derived: sum of 3 quarters · filed 2019-03-01
$205.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$486.00K
10-Q · filed 2018-05-04
-$847.00K
derived: sum of 2 quarters · filed 2019-03-01
-$767.00K
derived: sum of 3 quarters · filed 2019-03-01
-$268.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$361.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$281.00K
derived: sum of 2 quarters · filed 2019-03-01
$218.00K
derived: sum of 3 quarters · filed 2019-03-01
$1.31M
10-K · filed 2019-03-01
$986.00K
10-K · filed 2017-03-03
2016-09-30$80.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$579.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.67M
10-Q · filed 2017-11-08
-$1.67M
10-Q · filed 2016-11-09
$2.19M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$499.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$1.59M
10-Q · filed 2017-08-09
-$1.59M
10-Q · filed 2016-08-10
$2.11M
derived: sum of 3 quarters · filed 2018-03-08
$2.15M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$1.09M
10-Q · filed 2017-05-15
-$1.09M
10-Q · filed 2016-05-13
$1.61M
derived: sum of 2 quarters · filed 2018-03-08
$1.65M
derived: sum of 3 quarters · filed 2018-03-08
$1.60M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$520.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$558.00K
derived: sum of 2 quarters · filed 2018-03-08
$515.00K
derived: sum of 3 quarters · filed 2018-03-08
$373.00K
10-K · filed 2018-03-08
2015-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$5.00K
derived: sum of 2 quarters · filed 2016-11-09
-$147.00K
10-Q · filed 2016-11-09
2015-06-30-$43.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
-$185.00K
10-Q · filed 2016-08-10
2015-03-31-$142.00K
10-Q · filed 2016-05-13
2014-12-31$88.00K
10-K · filed 2017-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
REGENXBIO Inc. (RGNX)United States$0.477B-3.30